BOWMARK GROWTH GP LLP
ONE EAGLE PLACE, LONDON  SW1Y 6AF- Active
- Limited Liability Partnership
- Company No. OC433741
- Last Updated: 01 Mar 2024
Company Profile
BOWMARK GROWTH GP LLP was incorporated on Tuesday, October 13, 2020 as a Limited Liability Partnership with registered address in LONDON. BOWMARK GROWTH GP LLP has the status: Active. This Limited Liability Partnership has been operating for 3 years 11 months and 23 days.
Name | BOWMARK GROWTH GP LLP |
---|---|
Company number | OC433741 |
Company type | Limited Liability Partnership |
Incorporation date | 13 Oct 2020 |
Status | Active |
Address
Registered Address |
ONE EAGLE PLACE LONDON SW1Y 6AF |
---|---|
Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Michael Kevin Peter Grassby Nationality: British |
Dates: Tuesday, October 13, 2020 - present
significant influence or control limited liability partnership
|
Charles Thomas Messiter Ind Nationality: British |
Dates: Tuesday, October 13, 2020 - present
significant influence or control limited liability partnership
|
Bowmark Capital Partners Gp Limited SW1Y 6AF |
Dates: Tuesday, October 13, 2020 - present
voting rights 75 to 100 percent limited liability partnership
right to share surplus assets 75 to 100 percent limited liability partnership
|
Accounts and Confirmation
Type of accounts | SMALL |
---|---|
End of financial Year | 31 March |
Next annual accounts due | 31 December 2024, (86 days left) |
Latest accounts | 31 December 2022 |
Next confirmation statement due | 10 November 2021 |
Last confirmation statement dated | Not available |
Mortgages
Total of Mortgages | 1 |
---|---|
Mortgages Outstanding | 1 |
Mortgages Partially Satisfied | 0 |
Mortgages Satisfied/Paid | 0 |
Previous Names
Name | Change Date |
---|---|
BOWMARK GROWTH GP LLP | 13 Oct 2020 |
BOWMARK INVESTMENT GP LLP | 27 Feb 2021 |